MicroRNA in refined diagnosis of choroidal melanoma
https://doi.org/10.29413/ABS.2021-6.6-1.8
Abstract
Epigenetic studies of the level of microRNAs in human oncogenesis indicate their signifi cant role in the development and growth of malignant tumors of various origins. The fi rst works on the role of microRNAs in patients with uveal melanoma appeared in 2008.
The aim: to analyze the expression level of miRNA-126 and miRNA-223 in the plasma blood of patients and to determine their signifi cance in the refi ned diagnosis of choroidal melanoma.
Materials and methods. We examined 84 patients with choroidal melanoma (CM), mean age – 63.4 ± 1.2 (35–86 y.o.). Localization – a single CM node with a thickness of 0.77–17.19 mm. The control group consisted of 28 volunteers, age – 62.9 ± 1.42 (45–78 y.o.). Plasma miRNA expression levels were determined by real-time PCR.
Results. An increase in the level of expression of miRNA-223 and miRNA-126 in blood plasma was confi rmed in all 84 patients with choroidal melanoma N0M0 compared with the control group. An increase in the expression of miRNA-223 and miRNA-126 was proved with an increase in tumor prominence.
Conclusion. The obtained results of an increase in the expression of miRNA-223 indicate an increase in cell proliferation, and an increase in the expression of miRNA-126 on the activation of angiogenesis in a growing tumor, which makes it possible to recommend a study of the level of miRNA-223 and miRNA-126 for a more accurate diagnosis of small CM in cases of difficulty of differential diagnosis with other tumor-like diseases of the choroid.
About the Authors
A. F. BrovkinaRussian Federation
Dr. Sc. (Med.), Professor, Academician of RAS, Professor at the Department of Ophthalmology; Ophthalmologist at the Oncology Department
Barrikadnaya str. 2/1, Moscow 123995, Russian Federation
2nd Botkinsky dr. 5 build 19, Moscow 125284, Russian Federation
N. D. Tsybikova
Russian Federation
Postgraduate at the Department of Ophthalmology; Ophthalmologist at the Polyclinic Department No. 2
Barrikadnaya str. 2/1, Moscow 123995, Russian Federation
2nd Botkinsky dr. 5 build 19, Moscow 125284, Russian Federation
References
1. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006; 34(Database issue): D140-D144. doi: 10.1093/nar/gkj112
2. Shrivastava S, Steele R, Ray R, Ray RB. MicroRNAs: Role in hepatitis C virus pathogenesis. Genes Dis. 2015; 2(1): 35-45. doi: 10.1016/j.gendis.2015.01.001
3. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: From microRNA sequences to function. Nucleic Acids Res. 2019; 47(D1): D155-D162. doi: 10.1093/nar/gky1141
4. Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016; 1: 15004. doi: 10.1038/sigtrans.2015.4
5. Favero A, Segatto I, Perin T, Belletti B. The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response. Wiley Interdiscip Rev RNA. 2021; 12(6): e1659. doi: 10.1002/wrna.1659
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9): 2999-3004. doi: 10.1073/pnas.0307323101
7. Worley LA, Long MD, Onken MD, Harbour JW. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res. 2008; 18(3): 184-190. doi: 10.1097/CMR.0b013e3282feeac6
8. Radhakrishnan A, Badhrinarayanan N, Biswas J, Krishnakumar S. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma. Mol Vis. 2009; 15: 2146-2154.
9. Aughton K, Kalirai H, Coupland SE. MicroRNAs and uveal melanoma: Understanding the diverse role of these small molecular regulators. Int J Mol Sci. 2020; 21(16): 5648. doi: 10.3390/ijms21165648
10. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: The mystery of their origin and function. Trends Biochem Sci. 2012; 37(11): 460-465. doi: 10.1016/j.tibs.2012.08.003
11. Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009; 21(4): 575-581. doi: 10.1016/j.ceb.2009.03.007
12. Russo A, Caltabiano R, Longo A, Avitabile T, Franco LM, Bonfiglio V, et al. Increased levels of miRNA-146a in serum and histologic samples of patients with uveal melanoma. Front Pharmacol. 2016; 7: 424. doi: 10.3389/fphar.2016.00424
13. Rodríguez MFB, Fernandez MB, Baameiro LN, SantiagoVarela M, Silva-Rodríguez P, Blanco-Teijeiro MJ, et al. Blood biomarkers of uveal melanoma: Current Perspectives. Clin Ophthalmol. 2020; 14: 157-169. doi: 10.2147/OPTH.S199064
14. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005; 123(12): 1639-1643. doi: 10.1001/archopht.123.12.1639
15. Saakyan SV, Panteleeva OG, Shirina TV. Metastatic disease characteristics and survival of patients with uveal melanoma depending on the method of treatment of the primary tumor. Russian Ophthalmological Journal. 2012; 5(2): 55-58. (In Russ.).
16. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6): 1101-1108. doi: 10.1038/nprot.2008.73
17. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One. 2012; 7(7): e41629. doi: 10.1371/journal.pone.0041629.
18. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profi ling: The importance of miR-21 and miR-331. Br J Cancer. 2017; 117(2): 266-273. doi: 10.1038/bjc.2017.190
19. Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X, et al. NF-κB/miR-223-3p/ARID1A axis is involved in helicobacter pylori CagA-induced gastric carcinogenesis and progression. Cell Death Dis. 2018; 9(1): 12. doi: 10.1038/s41419-017-0020-9
20. Fassan M, Saraggi D, Balsamo L, Realdon S, Scarpa M, Castoro C, et al. Early miR-223 upregulation in gastroesophageal carcinogenesis. Am J Clin Pathol. 2017; 147(3): 301-308. doi: 10.1093/ajcp/aqx004
21. Bhattacharya S, Steele R, Shrivastava S, Chakraborty S, Di Bisceglie AM, Ray RB. Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma. Am J Pathol. 2016; 186(2): 242-247. doi: 10.1016/j.ajpath.2015.10.003
22. Khairy A, Hamza I, Shaker O, Yosry A. Serum miRNA panel in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. Asian Pac J Cancer Prev. 2016; 17(5): 2699-2703.
23. Bao S, Zheng J, Li N, Huang C, Chen M, Cheng Q, et al. Serum microRNA levels as a noninvasive diagnostic biomarker for the early diagnosis of hepatitis B virus-related liver fibrosis. Gut Liver. 2017; 11(6): 860-869. doi: 10.5009/gnl16560
24. Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012; 586(7): 1038-1043. doi: 10.1016/j.febslet.2012.02.050
25. Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol. 2014; 58(2): 182-186. doi: 10.1016/j.molimm.2013.11.018
26. Yang W, Lee DY, Ben-David Y. The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol. 2011; 3(2): 140-155.
27. Triozzi PL, Achberger S, Aldrich W, Crabb JW, Saunthararajah Y, Singh AD. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma. Clin Epigenetics. 2016; 8: 80. doi: 10.1186/s13148-016-0243-0
28. Li J, Guo Y, Liang X, Sun M, Wang G, De W, et al. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol. 2012; 138(5): 763-774. doi: 10.1007/s00432-012-1154-x
29. Brovkina AF, Sklyarova NV, Yurovskaya NN. Fluorescein angiography in the diagnosis of amelanotic choroidal melanomas. The Russian Annals of Ophthalmology. 2004; 120(6): 8-11. (In Russ.).
30. Grishina EE, Davydov DV, Stoyukhina AS. Enucleations in uveal melanoma (analysis of archival records). The Russian Annals of Ophthalmology. 2010; 126(2): 30-34. (In Russ.).
Review
For citations:
Brovkina A.F., Tsybikova N.D. MicroRNA in refined diagnosis of choroidal melanoma. Acta Biomedica Scientifica. 2021;6(6-1):65-73. (In Russ.) https://doi.org/10.29413/ABS.2021-6.6-1.8